Inotuzumab Human Monoclonal Antibody
Inotuzumabis a research-grade recombinant antibody targeting CD22. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
UniProt
P20273
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG4-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR216981L3V 200 µL
Slc39a14 (NM_144808) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
![Mouse Monoclonal MAML2 Antibody (MAML2/1302) [DyLight 594]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-54588DL594 0.1 mL
Mouse Monoclonal MAML2 Antibody (MAML2/1302) [DyLight 594]
Sign In for Pricing
View Details